-
Gemfibrozil, sold
under the
brand name
Lopid among others, is a
medication used to
treat abnormal blood lipid levels. It is
generally less
preferred than...
-
kidney failure.
Risks were
higher in
patients using fibrates,
mainly gemfibrozil (Lopid), and in
patients using the
highest (0.8 mg/day) dose of cerivastatin...
- that the
combined use of
statins and the
fibrate drug
class (such as
gemfibrozil, fenofibrate) may
increase the risk of
myopathy and rhabdomyolysis, there...
- of hypercholesterolemia, but the
combination of some
fibrates (e.g.,
gemfibrozil) with
statins is
contraindicated due to an
increased risk of rhabdomyolysis...
-
Additional medications for high
cholesterol such as clofibrate, fenofibrate,
gemfibrozil, and
niacin (when
taken in lipid-modifying
doses of 1 g/day and above)...
- ketoacidosis, with or
without coma Type 1
diabetes Co-administration with
gemfibrozil Known hy****nsitivity to drug or
inactive ingredients Common adverse...
-
Additional cholesterol-lowering
medications such as:
fenofibrate (Tricor),
gemfibrozil (Lopid),
cholestyramine (Questran,
Questran Light, Cholybar), and niacin...
- pravastatin, or simvastatin) were
combined with a
fibrate (fenofibrate or
gemfibrozil) treatment.
Cerivastatin was
withdrawn by its
manufacturer in 2001. Some...
- (prasterone) (in rodents)
Elafibranor Etomoxir Fenofibrate Genistein Gemfibrozil GW-7647
Lanifibranor Leukotriene B4 LG-101506 LG-100754 Lobeglitazone...
-
elevated transaminases and myopathy.
Fibric acid derivatives, such as
gemfibrozil and fenofibrate,
function by
increasing the
lipolysis in
adipose tissue...
